1. Home
  2. WABC vs GLUE Comparison

WABC vs GLUE Comparison

Compare WABC & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westamerica Bancorporation

WABC

Westamerica Bancorporation

N/A

Current Price

$58.75

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

Logo Monte Rosa Therapeutics Inc.

GLUE

Monte Rosa Therapeutics Inc.

N/A

Current Price

$11.25

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WABC
GLUE
Founded
1972
2019
Country
United States
United States
Employees
627
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
WABC
GLUE
Price
$58.75
$11.25
Analyst Decision
Hold
Strong Buy
Analyst Count
2
8
Target Price
★ $64.00
$28.50
AVG Volume (30 Days)
171.7K
★ 949.3K
Earning Date
10-15-2026
11-05-2026
Dividend Yield
★ 3.29%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 3.40
N/A
Revenue
N/A
★ $123,672,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ $17.19
$72.42
Revenue Growth
N/A
★ 63.54
52 Week Low
$44.93
$7.24
52 Week High
$63.61
$25.77

Technical Indicators

Market Signals
Indicator
WABC
GLUE
Relative Strength Index (RSI) 39.11 28.92
Support Level $55.80 N/A
Resistance Level $60.49 $15.00
Average True Range (ATR) 1.21 0.59
MACD -0.21 0.05
Stochastic Oscillator 0.00 9.06

Price Performance

Historical Comparison
WABC
GLUE

About WABC Westamerica Bancorporation

Westamerica Bancorp provides a full range of banking services to individual and commercial customers in Northern and Central California through its subsidiary bank. The Bank is a California-chartered commercial bank whose deposits are insured by the Federal Deposit Insurance Corporation (the FDIC) up to applicable limits. The principal communities served are located in Northern and Central California, from Mendocino, Lake and Nevada Counties in the north to Kern County in the south. The Company's strategic focus is on the banking needs of small businesses.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).

Share on Social Networks: